Total Clarity Wealth Management, Inc. Myovant Sciences Ltd. Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$7.78 - $14.69 $3,890 - $7,345	500 New	500 $6,000
Q1 2022 Apr 29, 2022	SELL	$11.38 - $16.4 $5,690 - $8,200	-500 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$14.31 - $23.87 $5,008 - $8,354	-350 Reduced 41.18%	500 $8,000
Q3 2021 Oct 21, 2021	BUY	$18.94 - $26.99 $16,099 - $22,941	850 New	850 $19,000
Q2 2021 Jul 26, 2021	SELL	$17.07 - $24.56 $5,974 - $8,596	-350 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$20.46 - $25.18 $7,161 - $8,813	350 New	350 $7,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.